Trial Profile
Nimotuzumab + vinorelbine + radiotherapy in paediatric patients with diffuse pontine gliomas
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Sep 2015
Price :
$35
*
At a glance
- Drugs Nimotuzumab (Primary) ; Vinorelbine (Primary)
- Indications Glioma
- Focus Therapeutic Use
- 01 Sep 2015 New trial record